Related Experiment Video
Updated: Jan 9, 2026

Use of Galleria mellonella as a Model Organism to Study Legionella pneumophila Infection
Published on: November 22, 2013
Lethal Legionella Pneumonia With Bacteremia Due to Serotype 3 Co-infected With Staphylococcus aureus and Haemophilus
Yuzo Obata1, Masafumi Seki2, Shuhei Miyata1
1Department of Trauma and Emergency Acute Medicine, Saitama Medical University International Medical Center, Hidaka, JPN.
Abstract:
A 66-year-old man with no relevant medical history developed pneumonia. Urine antigen tests for pneumococcus and Legionella serotype 1 (the most common serotype) were negative, but sputum culture was positive for methicillin-susceptible Staphylococcus aureus (MSSA) and β-lactamase-negative Haemophilus influenzae (BLNAR). The patient was treated with meropenem and azithromycin, but an aerobic blood culture became positive on day 4, and mass spectrometry analysis indicated the presence of Legionella species. Subculture on buNrNL charcoal yeast extract (BCYE)-α agar identified Legionella pneumophila serotype 3. The patient was diagnosed with pneumonia caused by MSSA and BLNAR, as well as pneumonia/bacteremia due to Legionella pneumophila serotype 3. Despite changing the antibiotics to meropenem plus lascufloxacin and adding hydrocortisone and venovenous extracorporeal membrane oxygenation (V-V ECMO), the patient died. In patients with severe pneumonia, co-infection with Legionella species, including rare serotypes, should be considered, and universal rapid antigen tests are necessary to ensure rapid diagnosis and appropriate treatment.
Related Concept Videos
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia III: Complications and Assessment
Pneumonia II: Pathophysiology
Bacterial Phylum Spirochaetes
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:

